Torex Gold Resources Ltd. (0VL5)
London Exchange · UK · prices in CAD · close of 19 Oct 2026
Key indicators
| Last close | CAD 73.74 |
|---|---|
| 52-week range | 43.86 – 84.41 |
| Return, 1 month / 3 months | +10.1% / +33.8% |
| Return, 1 year / 3 years | +70.5% / – |
| Trend | Uptrend |
| RSI (14) | 58 |
| Volatility (1 year) | 62.2% |
| Worst drawdown (1 year) | -37.1% |
| Average daily value traded | 0.03M CAD |
| Dividend yield | 0.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Torex Gold Resources is a gold mining company based in Canada that operates the Morelos gold property in Guerrero, Mexico. The company extracts gold, and also produces silver and copper as by-products, from its open-pit and underground operations at the site. Its activities cover mining, processing and refining ore into doré bars, which are then shipped to refiners. Torex Gold Resources serves the global precious metals market through the sale of its gold and associated metals.
Torex Gold Resources Ltd. trades under the code 0VL5 on the London Exchange in UK, with its price quoted in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in 2 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Torex Gold Resources Ltd. (0VL5) trades on the London Exchange in UK. It last closed at CAD 73.74 on 19 October 2026.
Its price-based Market X-Ray is 50 out of 100 (a fair price profile), ranking 2,071 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 70.5% and over the last three months it rose 33.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 71 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 14.3% | ||
| From 52-week high | -11.8% | ||
| Momentum | 81 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 33.8% | ||
| 6-month return | 9.4% | ||
| 12-month return, skipping the last month | – | ||
| Stability (higher is calmer) | 27 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 62.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -37.1% | ||
| Liquidity | 20 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.03M CAD | ||
| Zero-volume days | 0.0% | ||
| Income | 24 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.8% | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +4.1% |
|---|---|
| 1 month | +10.1% |
| 3 months | +33.8% |
| 6 months | +9.4% |
| 1 year | +70.5% |
| 3 years | – |
| 5 years | – |
Signals
| 50-day / 200-day average | 68.22 / 64.53 |
|---|---|
| Golden / death cross (60 days) | Golden, 12 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.74 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Aug 2026 | CAD 0.1600 |
| 21 May 2026 | CAD 0.1600 |
| 5 Mar 2026 | CAD 0.1500 |
| 20 Nov 2025 | CAD 0.1500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.